spironolactone has been researched along with metolazone in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (43.48) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Arruda, JA; Dhupelia, VB; Kane, RE; Lang, GR; Nascimento, L; Westenfelder, C | 1 |
| Lief, PD | 1 |
| Greenberg, A | 1 |
| Cobb, SD; Miller, SA; Petrulis, AS; Vertes, V | 1 |
| Clarke, JM; Harrison, IR; McInnes, GT; Perkins, RM; Shelton, JR | 2 |
| Clarke, JM; McInnes, GT; Shelton, JR | 1 |
| Barrett, JD; Eggena, P; Golub, MS; Sambhi, MP; Thananopavarn, C | 1 |
| Herbinger, W | 1 |
| McInnes, GT; Muirhead, DC; Palmer, RF; Stevens, PM; Vose, CW | 1 |
| Allen, LV; Erickson, MA | 1 |
| Blue, L; McMurray, J | 1 |
| Hoyer, RJ; Lacy, MQ; Leung, N; Witzig, TE | 1 |
| Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W | 1 |
| Barfod, T; Klit, J; Rasmussen, ZZ | 1 |
| Bradley, TD; Friedman, O; Kasai, T; Logan, AG | 1 |
| Aliaga, S; Chantala, K; Clark, RH; Herring, AH; Hornik, CP; Hughes, R; Laughon, MM; Smith, PB | 1 |
2 review(s) available for spironolactone and metolazone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
How much responsibility should heart failure nurses take?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Comorbidity; Diuretics; Heart Failure; Humans; Metolazone; Nurse Clinicians; Nurse Practitioners; Nurse's Role; Practice Guidelines as Topic; Sodium Chloride Symporter Inhibitors; Spironolactone | 2005 |
3 trial(s) available for spironolactone and metolazone
| Article | Year |
|---|---|
Metolazone and spironolactone in cirrhosis and the nephrotic syndrome.
Topics: Adult; Aged; Blood Cell Count; Blood Glucose; Blood Pressure; Body Weight; Chlorides; Clinical Trials as Topic; Creatinine; Diuresis; Diuretics; Drug Interactions; Drug Therapy, Combination; Humans; Liver Cirrhosis; Male; Metolazone; Middle Aged; Nephrotic Syndrome; Potassium; Sodium; Spironolactone | 1977 |
Step 1 1/2 therapy for the treatment of hypertension.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Diuretics; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metolazone; Middle Aged; Potassium; Spironolactone | 1985 |
Use of a bioassay in healthy men to evaluate diuretic-spironolactone combinations.
Topics: Adult; Diuretics; Double-Blind Method; Drug Combinations; Humans; Male; Metolazone; Potassium; Spironolactone | 1983 |
18 other study(ies) available for spironolactone and metolazone
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Diuretics.
Topics: Benzothiadiazines; Chlorthalidone; Diuretics; Ethacrynic Acid; Furosemide; Humans; Kidney; Kidney Tubules, Distal; Loop of Henle; Metolazone; Nephrons; Sodium Chloride Symporter Inhibitors; Spironolactone; Triamterene | 1978 |
What's new in diuretic therapy.
Topics: Acetazolamide; Acid-Base Imbalance; Biological Transport; Diuretics; Drug Resistance; Ethacrynic Acid; Furosemide; Humans; Hydrochlorothiazide; Hyperkalemia; Hypernatremia; Hypokalemia; Hyponatremia; Indapamide; Kidney Tubules, Distal; Kidney Tubules, Proximal; Loop of Henle; Metolazone; Osmolar Concentration; Spironolactone; Triamterene; Vasopressins | 1986 |
Relative potency of prorenoate potassium and spironolactone in attenuating diuretic induced hypokalaemia.
Topics: Adult; Canrenone; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Metolazone; Mineralocorticoid Receptor Antagonists; Potassium; Spironolactone | 1984 |
Dose-response relationships for spironolactone in combination with a potassium-wasting diuretic.
Topics: Adult; Diuretics; Dose-Response Relationship, Drug; Drug Evaluation; Drug Interactions; Humans; Male; Metolazone; Potassium; Sodium; Spironolactone | 1983 |
Angiotensin II, plasma renin and sodium depletion as determinants of blood pressure response to saralasin in essential hypertension.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hypertension; Hyponatremia; Infusions, Parenteral; Male; Metolazone; Middle Aged; Renin; Saralasin; Sodium; Spironolactone | 1980 |
[Diuretics in the therapy of chronic cardiac insufficiency].
Topics: Acetazolamide; Amiloride; Diuretics; Drug Interactions; Ethacrynic Acid; Heart Failure; Humans; Indapamide; Metolazone; Risk; Spironolactone; Sulfonamides; Thiazoles; Ticrynafen; Triamterene | 1982 |
A fluorimetric assay for metolazone in urine.
Topics: Diuretics; Humans; Kinetics; Methods; Metolazone; Spectrometry, Fluorescence; Spironolactone | 1980 |
Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Antifungal Agents; Antihypertensive Agents; Antitrichomonal Agents; Chromatography, High Pressure Liquid; Diuretics; Dosage Forms; Drug Compounding; Drug Stability; Humans; Hydrogen-Ion Concentration; Ketoconazole; Metolazone; Metronidazole; Pharmaceutical Vehicles; Procainamide; Solubility; Spironolactone; Suspensions | 1996 |
Treatment of diuretic refractory pleural effusions with bevacizumab in four patients with primary systemic amyloidosis.
Topics: Amyloidosis; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Captopril; Chest Tubes; Combined Modality Therapy; Dexamethasone; Diuretics; Drug Resistance; Edema; Fatal Outcome; Furosemide; Humans; Hypoalbuminemia; Male; Melphalan; Metolazone; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Peripheral Blood Stem Cell Transplantation; Pleural Effusion; Prednisolone; Serum Albumin; Spironolactone; Thalidomide; Thoracostomy; Transplantation, Autologous; Vascular Endothelial Growth Factor A | 2007 |
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Atorvastatin; Calcium Carbonate; Cardiomyopathy, Restrictive; Citalopram; Connective Tissue Diseases; Diuretics; Female; Furosemide; Glucosamine; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperpigmentation; Lupus Erythematosus, Systemic; Magnesium; Metolazone; Middle Aged; Naproxen; Omeprazole; Potassium Chloride; Prednisone; Pyrroles; Selective Serotonin Reuptake Inhibitors; Spironolactone | 2008 |
[Renal effect of treatment for heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathies; Diuretics; Furosemide; Heart Failure; Humans; Kidney; Male; Metolazone; Middle Aged; Ramipril; Spironolactone; Uremia | 2009 |
Effect of intensified diuretic therapy on overnight rostral fluid shift and obstructive sleep apnoea in patients with uncontrolled hypertension.
Topics: Aged; Blood Pressure; Diuretics; Drug Resistance; Drug Therapy, Combination; Extracellular Fluid; Female; Fluid Shifts; Humans; Hypertension; Leg; Male; Metolazone; Middle Aged; Neck; Polysomnography; Sleep Apnea, Obstructive; Spironolactone | 2014 |
Diuretic exposure in premature infants from 1997 to 2011.
Topics: Acetazolamide; Amiloride; Bronchopulmonary Dysplasia; Chlorothiazide; Cohort Studies; Diazoxide; Diuretics; Drug Therapy, Combination; Ethacrynic Acid; Female; Furosemide; Humans; Hydrochlorothiazide; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Male; Mannitol; Metolazone; Off-Label Use; Respiration, Artificial; Retrospective Studies; Spironolactone; Thrombocytopenia | 2015 |